Medical aesthetic company E.S.I Novel, part of Essence Group, has now launched its skin analyser and energy treatment device JÓLI360 to clinics.
JÓLI360 launched in 2018, but was still in the early stages of research and development and was not yet available for purchase.
The JÓLI360 device features two hand pieces; a skin analyser that measures skin conditions for hydration, elasticity and sebum, and a treatment handpiece.
Following skin analysis, data is transferred onto a JÓLI360 touchscreen tablet, allowing practitioners to provide personalised treatments based on skin’s condition and patient’s needs.
The treatment is then performed by the practitioner using the handpiece featuring low level laser therapy, bipolar radiofrequency and electroporation.
JÓLI360 has completed a preliminary clinical evaluation by Professor Stefano Verardi, specialist in plastic, reconstructive and aesthetic surgery at the University of Rome Tor Vergata. The evaluation involved 50 patients and showed a reduction in the number and severity of wrinkles, a persistent improvement in elastosis, and a reduction in brown and UV spots, porphyrin effect and in the amelioration of texture, with no observed side effects.
Dr Haim Amir, CEO and founder of Essence Group said, “Essence Group is driven by its constant desire to innovate, expand the company’s horizons, and reach new markets. The launch of JÓLI360 reflects this commitment to revolutionary technology across the internet of things (IoT) sector. This disruptive technology offers cosmeticians, spa owners and clinics with an end-to-end solution that promises to be a game-changer in the aesthetic industry.”
Barak Katz, GM at E.S.I. Novel added, “We are delighted to bring to market our innovative aesthetic product, JÓLI360. Our product offers cosmeticians a gateway to a new world of cosmetic treatments. This compact and portable system boosts any clinic's capabilities, and positions cosmeticians at the forefront of the professional world of beauty.”